Description
Simplicity in every analysis. Power in every insight. The BioAccord LC-MS System is designed for definition and monitoring of biotherapeutic attributes across biopharmaceutical process and product development, manufacturing, and QC. It accomplishes these tasks within a small benchtop footprint on a platform capable of operation by non-MS experts. Analyze a broad range of protein product attributes at the intact, subunit, peptide map, and released glycan levels. Analyze oligonucleotide and nucleic acid products using intact mass confirmation, MS1 digested fragment mapping, and deeper MS2 based sequence confirmation. Assess bioprocess effectiveness and robustness by studying cell culture media and product attributes.
- Make rapid, confident decisions with accessible, consistent high-quality data?.
- Analyze complex biomolecules with greater selectivity, specificity, and dynamic range than optical detection based chromatographic and electrophoretic methods.
- Ensure operational simplicity, result consistency, and lab productivity with full workflow automation?.
- Deploy compliance-ready waters_connect network-scalable informatics, supporting a combination of HRMS (QTof and BioAccord) and optical-only detection systems from early product characterization to final product release.